The cytotoxic activities of three new synthetic
catechol analogues, beta-[(p-hydroxyphenyl)amino]
alanine (Compound 1), N delta-(p-hydroxyphenyl)
ornithine (Compound 2), and N delta-(m-hydroxyphenyl)
ornithine (Compound 3), were determined against 10 human
melanoma and 5 nonmelanoma cell lines. Activities of
L-DOPA and
3,4-dihydroxybenzylamine were also measured. Dose-response curves were obtained and concentrations in micrograms/ml required to give 90% inhibition of colony formation (IC90) were calculated. Using a cutoff IC90 of less than 2.5 as a definition of activity. Compound 2 was active in 6 of 10
melanoma and 0 of 5 nonmelanoma cell lines while both Compound 1 and
L-DOPA methyl ester were active in 1 of 10
melanomas and 0 of 5 nonmelanomas. Compound 3 was inactive in all cell lines and all IC90 values exceeded 100.
3,4-Dihydroxybenzylamine was active in 3 of 8
melanomas and 1 of 5 nonmelanomas. Regression analysis of IC90 values for Compound 2 and
tyrosinase levels in the 15 cell lines yielded a correlation coefficient of 0.93 (P less than 0.001). By contrast, a similar analysis for
3,4-dihydroxybenzylamine gave a correlation coefficient of 0.17 (P greater than 0.05). Spectrophotometric data indicated that Compounds 1 and 2 were oxidized by
tyrosinase to
quinones. Cytotoxic activity was blocked by the
tyrosinase inhibitor
phenylthiocarbamide. Since the rates of activation of Compounds 1 and 2 were identical, the higher activity of Compound 2 was probably due to its higher lipophilicity and greater intracellular accumulation. Compounds 1 and 2 exhibited greater potency and selectivity against
malignant melanoma than did the
natural product L-DOPA methyl ester.